| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |